Author: ALLISON GATLIN
Source
Dexcom’s revenue could reach $5 billion in 2025, the company said Friday as it announced a new CGM device. Dexcom stock could soar again.
The post Dexcom, A Top 2% Stock, Raises 2025 Outlook Amid ‘Rapidly’ Expanding Diabetes Market appeared first on Investor’s Business Daily.